We first examined the expression of LKB1/AMPK signaling in various CKD models, including unilateral ureteral obstruction (UUO), 5/6 nephrectomy (5/6NX), and adriamycin nephropathy (ADR). This evidence concerns the gene PRKAA1 and chronic kidney disease.